Sponsor
1 Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial JACC - Journal of the American College of Cardiology, May 10, 2013
2 New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: More Choices Bring More Challenges Hospital Pharmacy, May 8, 2013 Review Article
3 Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care International Journal of Clinical Practice, May 7, 2013
4 Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation New England Journal of Medicine, May 17, 2013 Evidence Based Medicine
5 Impact of double-blind versus open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis Journal of Thrombosis and Haemostasis, May 10, 2013 Evidence Based Medicine Review Article
6 Use of New Oral Anticoagulants in Antiphospholipid Syndrome Current Rheumatology Reports, May 7, 2013
7 Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter Journal of Interventional Cardiac Electrophysiology , May 1, 2013
8 In-hospital case management to increase anticoagulation therapy for stroke patients with atrial fibrillation: A hospital-based registry Journal of the Formosan Medical Association, May 15, 2013
9 Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation Clinical Interventions in Aging, May 20, 2013
10 Left Atrial Massive Thrombus Formation on the Transseptal Sheath Despite Adequate Anticoagulation with Warfarin and Heparin During Pulmonary Vein Isolation Journal of Cardiovascular Electrophysiology, May 22, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor